Back
Barclays PLC Vs. SpringWorks Therapeutics Industry Stock Comparison
Buy
66
BCLYF
Barclays PLC
Last Price:
$4.21
Seasonality Move:
-1.12%
Sell
29
SWTX
SpringWorks Therapeutics
Last Price:
$46.09
Seasonality Move:
6.26%
Buy
66
Barclays PLC (BCLYF)
is a Buy
Is Barclays PLC a Buy, Sell or Hold?
-
The current Barclays PLC [BCLYF] share price is $4.21. The Score for BCLYF is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
BCLYF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $46.08. The Score for SWTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCLYF Stock Price Chart
What is Barclays PLC's stock price today?
-
The Barclays PLC share price today is $4.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCLYF is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $46.08The current trend is moderately bullish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
BCLYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 60.23 | Buy |
Chaikin Money Flow: | -5386 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.58 - 4.08) | Buy |
Bollinger Bands (100): | (3.4 - 3.94) | Buy |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.89 | Buy |
Relative Strength Index (14 RSI): | 57.7 | Buy |
Chaikin Money Flow: | -4614643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.96 - 47.2) | Buy |
Bollinger Bands (100): | (36.52 - 51.04) | Buy |
BCLYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.07 | Buy |
20-day SMA: | 3.92 | Buy |
50-day SMA: | 3.79 | Buy |
200-day SMA: | 3.36 | Buy |
8-day EMA: | 4.1 | Buy |
20-day EMA: | 3.95 | Buy |
50-day EMA: | 3.81 | Buy |
200-day EMA: | 3.39 | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.18 | Sell |
20-day SMA: | 44.66 | Buy |
50-day SMA: | 44.86 | Buy |
200-day SMA: | 39.77 | Buy |
8-day EMA: | 46.03 | Buy |
20-day EMA: | 45.01 | Buy |
50-day EMA: | 44.55 | Buy |
200-day EMA: | 41.59 | Buy |
Barclays PLC Earnings Growth & BCLYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $3.01 per share.
Barclays PLC Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |